[Combined therapy of inoperable esophageal cancer]. 1991

U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert

UI MeSH Term Description Entries
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
January 2006, Voprosy onkologii,
U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
January 1990, Radiobiologia, radiotherapia,
U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
June 1988, Nihon Gan Chiryo Gakkai shi,
U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
November 1981, Meditsinskaia radiologiia,
U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
March 1958, L'union medicale du Canada,
U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
April 1993, Japanese journal of clinical oncology,
U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
December 1983, Soins. Chirurgie (Paris, France : 1982),
U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
July 1994, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
October 1980, Tumori,
U Fink, and G Pfeiffer, and A Gossmann, and P Lukas, and H J Wilke, and P Preusser, and J R Siewert
July 1987, Gan no rinsho. Japan journal of cancer clinics,
Copied contents to your clipboard!